Clinical, demographic, and laboratory data points from our cohort were used for calculation of published Japanese risk scores15, 16, 17, 18 (Table 1). Cut points specified by the authors of each risk score were applied to determine whether a patient's risk was considered to be high or low.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.